Table 1.
Demographic and surgical characteristics of the patients
| Group-I | Group-II | Group-III | Group-IV | P value | ||
|---|---|---|---|---|---|---|
| Anti-seizures medication used |
Zonisamide n = 1 (%2,9) |
Topiramate n = 5 (%14,3) |
Lacosamide n = 5 (%14,3) |
Carbamazepine n = 4 (%11,4) |
Levetiracetam n = 20 (%57,1) |
|
| Age, year, mean ± SD | 20 | 32 ± 6 | 32 ± 4 | 55 ± 6 | 57 ± 10 | < 0.001 |
| Gender, n, female/male | 0 / 1 | 1 / 4 | 5 / 0 | 3 / 1 | 11 / 9 | 0.03 |
| ASA, n, II/III | 1 / 0 | 5 / 0 | 5 / 0 | 4 / 0 | 17 / 3 | |
| BMI, mean ± SD | 23 | 26 ± 2 | 25 ± 2 | 27 ± 1 | 28 ± 3 | 0.29 |
| Surgical pathology, n, ICS/Epilepsy surgery | 0 / 1 | 0 / 5 | 0 / 5 | 4 / 0 | 20 / 0 | |
| Duration of Surgery, min, mean ± SD | 300 | 222 ± 78 | 229 ± 70 | 237 ± 47 | 244 ± 53 | 0.95 |
Continuous variables are expressed as either the mean ± standard deviation (SD) and categorical variables are expressed as either frequency. Continuous variables were compared with Welch’s and Fisher’s One-Way ANOVA tests or Robust ANOVA test. Categorical variables were compared using Pearson’s chi-square test or fisher exact test. Statistically significant p-values are in bold ASA American Society of Anaesthesiologists, BMI body mass index, ICS intracranial surgery, min: minute, SD standard deviation